JAK2 in Myeloproliferative Neoplasms: Still a Protagonist
The discovery of the activating V617F mutation in Janus kinase 2 (JAK2) has been decisive for the understanding of myeloproliferative neoplasms (MPN). Activated JAK2 signaling by <i>JAK2</i>, <i>CALR,</i> and <i>MPL</i> mutations has become a focus for the develop...
Furkejuvvon:
Váldodahkkit: | , |
---|---|
Materiálatiipa: | Girji |
Almmustuhtton: |
MDPI AG,
2022-01-01T00:00:00Z.
|
Fáttát: | |
Liŋkkat: | Connect to this object online. |
Fáddágilkorat: |
Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
Lasit vuosttaš kommeantta. Visot kommeanttat leat almmolaččat.!